Search research articles
Contact Us
Filters
Showing results (91-100 of 149) with videos related to
Page
of 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2018
Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation
Laura J Sim-Selley, Jenny L Wilkerson, James J Burston, et al.
Journal of Medicinal Chemistry
|
November 30, 2019
Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators
Hongguang Ma, Samuel Obeng, Huiqun Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 12, 2005
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles
John W Huffman, Paul V Szklennik, Amanda Almond, et al.
Neuropharmacology
|
September 21, 2010
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
Steven G Kinsey, Anu Mahadevan, Bingjun Zhao, et al.
ACS Medicinal Chemistry Letters
|
January 21, 2017
Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation
Guoyan G Xu, Olga Yu Zolotarskaya, Dwight A Williams, et al.
Journal of Neurochemistry
|
August 12, 2016
Cannabinoid receptor interacting protein suppresses agonist-driven CB<sub>1</sub> receptor internalization and regulates receptor replenishment in an agonist-biased manner
Lawrence C Blume, Sandra Leone-Kabler, Deborah J Luessen, et al.
Journal of Basic and Clinical Physiology and Pharmacology
|
May 6, 2016
Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497
Travis W Grim, Kimberly L Samano, Bogna Ignatowska-Jankowska, et al.
Journal of Medicinal Chemistry
|
January 22, 2026
Investigating the Landscape of C6-Azaindole Side Chain on the Epoxymorphinan Skeleton via the Nitrogen Walk Concept: A Strategy to Enhance Drug-Like Properties
Logan Neel, Hongguang Ma, Ahmed Reda, et al.
Psychopharmacology
|
May 12, 2011
delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory
Laura E Wise, Stephen A Varvel, Dana E Selley, et al.
Bioorganic & Medicinal Chemistry
|
March 19, 2015
Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands
Yunyun Yuan, Saheem A Zaidi, David L Stevens, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 149) with videos related to
Sort By:
Page
of 15
The Journal of Pharmacology and Experimental Therapeutics
|
June 28, 2018
Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation
Laura J Sim-Selley, Jenny L Wilkerson, James J Burston, et al.
Journal of Medicinal Chemistry
|
November 30, 2019
Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators
Hongguang Ma, Samuel Obeng, Huiqun Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 12, 2005
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles
John W Huffman, Paul V Szklennik, Amanda Almond, et al.
Neuropharmacology
|
September 21, 2010
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
Steven G Kinsey, Anu Mahadevan, Bingjun Zhao, et al.
ACS Medicinal Chemistry Letters
|
January 21, 2017
Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation
Guoyan G Xu, Olga Yu Zolotarskaya, Dwight A Williams, et al.
Journal of Neurochemistry
|
August 12, 2016
Cannabinoid receptor interacting protein suppresses agonist-driven CB<sub>1</sub> receptor internalization and regulates receptor replenishment in an agonist-biased manner
Lawrence C Blume, Sandra Leone-Kabler, Deborah J Luessen, et al.
Journal of Basic and Clinical Physiology and Pharmacology
|
May 6, 2016
Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497
Travis W Grim, Kimberly L Samano, Bogna Ignatowska-Jankowska, et al.
Journal of Medicinal Chemistry
|
January 22, 2026
Investigating the Landscape of C6-Azaindole Side Chain on the Epoxymorphinan Skeleton via the Nitrogen Walk Concept: A Strategy to Enhance Drug-Like Properties
Logan Neel, Hongguang Ma, Ahmed Reda, et al.
Psychopharmacology
|
May 12, 2011
delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory
Laura E Wise, Stephen A Varvel, Dana E Selley, et al.
Bioorganic & Medicinal Chemistry
|
March 19, 2015
Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands
Yunyun Yuan, Saheem A Zaidi, David L Stevens, et al.
Page
of 15